Stock Price Quote

CAPSUGEL HEALTHCARE LTD.

NSE : NABSE : 506887ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : MNC
BSE77.750 (0 %)
PREV CLOSE ( ) 77.75
OPEN PRICE ( ) 79.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )75.70 79.85
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-12 1982
Management Info
- Chairman - Managing Director
Registered Office

Address 21, Joniawas,Dharuhera, ,
Rewari,
Haryana-122100

Phone 1274-267092

Email geetika.vashisth@lonza.com

Website www.capsugel.com

Registrars Details
Not Available
Listing :

NEWS

No News Found

Financials

in Millions
QTR Jun 05 ANNUAL 05
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26643.70 (0.58%)
M.Cap ( in Cr)56616.00
Pfizer (BSE)
peergroup  4473.85 (1.59%)
M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE)
peergroup  2355.75 (2.80%)
M.Cap ( in Cr)39907.83
Concord Biotech (BSE)
peergroup  1494.85 (4.43%)
M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE)
peergroup  1104.45 (5.00%)
M.Cap ( in Cr)111133.51

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Capsugel Healthcare Ltd.

Capsugel Healthcare Ltd. was incorporated in the year 1982. Its today's share price is 77.75. Its current market capitalisation stands at Rs 1644.46 Cr. In the latest quarter, company has reported Gross Sales of Rs. 913.12 Cr and Total Income of Rs.829.94 Cr. The company's management includes Olivier Gregory Johan Van Hoorebeke, Shubhi Khurana, Saurabh Rajpal, Guido Edouard Driesen, Abhishek Anand.

It is listed on the BSE with a BSE Code of 506887 , NSE with an NSE Symbol of and ISIN of . It's Registered office is at 21, Joniawas,Dharuhera, Rewari-122100, Haryana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, BSR & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.